Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF) has launched its campaign on the Investing News Network’s cannabis channel.

Chemistree Technology is building a portfolio of vertically-integrated cannabis assets across North America. By leveraging an elite team of cannabis veterans, Chemistree is building a multi-state network of cannabis operations in cultivation, processing, distribution and retail. Chemistree owns the operational assets and national branding rights to Sugarleaf, a Washington-based cannabis brand. Sugarleaf’s premium cannabis products are available in dispensaries across the state.

In addition to its Washington operations, Chemistree has begun expansion into California’s emerging cannabis market as well. The company has been granted a Conditional Use Permit (CUP) by the city of Desert Hot Springs, which Chemistree will use to develop its 9.55-acre property in California’s cannabis cultivation zone. Chemistree intends to continue to develop its Sugarleaf brand with distribution throughout the state of California in the future.

Chemistree Technology’s company highlights include the following:

  • Vertically-integrated company expanding into premiere cannabis jurisdictions in the US and beyond.
  • Team of true cannabis entrepreneurs with decades of experience in managing all aspects of profitable cannabis businesses including branding, cultivation, manufacturing and finance.
  • Strong foothold in Washington State, a market with nearly 750,000 recreational cannabis consumers.
  • Immediate access to one of the world’s biggest cannabis markets via California Processor’s License for Sugarleaf-branded products.
  • Granted CUP license at 9.55-acre Desert Hot Springs property.
  • Plans in 2019 to increase cultivation yield at Sugarleaf facility, expand retail footprint, product offerings and develop Desert Hot Springs greenhouse cultivation facility.
  • Well-financed with $10,830,000 capital raise completed in March 2019.
  • Tight share structure with management and consultants holding 50 percent of shares, representing more than $2 million in insider investment.

Click here to see the educational profile for Chemistree Technology Inc. (CSE:CHM; OTC:CHMJF) and to request an investor presentation.

Strong Innovation Pipeline Continues to Drive Market Share Growth
Broken Coast’s First Foray into Cannabis 2.0
Solei Introduces First Limited Release Vape on the Market
Solei, RIFF, Good Supply and B!NGO Expand Product Offerings

Aphria Inc. (” Aphria ” or the ” Company “) ( TSX: APHA and NASDAQ: APHA ), a leading global cannabis company inspiring and empowering the worldwide community to live their very best life, today announced the expansion of its 510 Vape offering across its award-winning adult-use brand portfolio.

Keep reading... Show less

Zhang Investor Law announces a class action lawsuit on behalf of shareholders who bought shares of Aurora Cannabis Inc. (NYSE: ACB) between February 13, 2020 and September 4, 2020, inclusive (the “Class Period”). If you wish to serve as lead plaintiff, you must move the Court before the December 1 2020 DEADLINE . A lead plaintiff is a representative party acting on behalf of other class members in directing the litigation.

To join the class action, go to or call Sophie Zhang, Esq. toll-free at 800-991-3756 or email for information on the class action.

Keep reading... Show less

Nextleaf Solutions Ltd. (CSE: OILS) (OTCQB: OILFF) (“Nextleaf Solutions“, “OILS”, or the “Company”), Canada’s most innovative cannabis extractor, is pleased to provide the following commercial and intellectual property update:

Cannabis Extraction Agreement with White Label Producer

Keep reading... Show less


Khiron Life Sciences Corp. (“ Khiron ” or, the “ Company ”) (TSXV: KHRN), (OTCQB: KHRNF), (Frankfurt: A2JMZC), a vertically integrated cannabis leader with core operations in Latin America and Europe, is pleased to announce that it has closed today its previously announced “bought deal” short form prospectus offering of units (“ Unit s ”), including the exercise in full of the over-allotment option (the “ Offering ”).

Keep reading... Show less

Cronos Group Inc. (NASDAQ: CRON) (TSX: CRON) (“Cronos Group” or the “Company”), an innovative global cannabinoid company, today announced that Mike Gorenstein, Executive Chairman, is scheduled to speak on a panel at the Cowen 2020 Boston Cannabis Conference on Wednesday, December 2, 2020 at 9:20 a.m. EST.

For more information regarding the Cowen 2020 Boston Cannabis Conference please visit:

Keep reading... Show less